US Stocks
/
Candel Therapeutics, Inc. Share Price

Candel Therapeutics, Inc. Share Price

NASDAQ: CADL | Small Cap
$9.68
-$0.13 (-1.38%) Last updated on 09 Oct, 2026 | 00:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Candel Therapeutics, Inc. Stock Performance

Open
$9.65
Prev. Close
$9.81
Circuit Range
N/A
Day Range
$9.45 - $9.74
Year Range
$4.36 - $14.00
Volume
22,917
Average Traded
$9.58

Candel Therapeutics, Inc. Share Price Today

As of 9 October 2026, Candel Therapeutics, Inc.'s share price is $9.68. The stock opened at $9.65, compared to its previous close of $9.81. During today's trading session, Candel Therapeutics, Inc.'s share price traded between $9.45 and $9.74, with an average price of $9.59. Over the past 52 weeks, the stock has recorded a high of $14.00 and a low of $4.36. In terms of performance, Candel Therapeutics, Inc.'s share price has risen by 56.89% over the last six months and is up 79.93% on a year-on-year basis.

Candel Therapeutics, Inc. Share Price Chart

$9.45$9.74
L
Show Current Price
H

Candel Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$512.64M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.16
Revenue (TTM)
$0.00
Return On Equity (TTM)
-70.19%
Profit Margin
N/A
Debt to Equity
0.38
Quarterly Earnings Growth YoY
-245.25%

Candel Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$11.27-$29.50-$8.86-$38.91
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-161.76%69.97%-339.16%

Candel Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.13$0.00$0.00$0.00
Net Profit-$18.79-$37.94-$55.18-$38.18
Net Profit Margin-14453.85%N/AN/AN/A
Income ChangeN/A-101.92%-45.44%30.81%

About Candel Therapeutics, Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Candel Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$10.42
$9.68
-7.46%
Sep 2026
$13.03
$10.46
-23.95%
Aug 2026
$9.66
$13.76
+37.55%
Jul 2026
$10.59
$10.00
-2.91%
Jun 2026
$8.34
$10.30
+24.17%
May 2026
$6.22
$8.29
+34.44%
Apr 2026
$4.93
$6.17
+25.66%
Mar 2026
$5.10
$4.91
-6.30%
Feb 2026
$5.80
$5.24
-10.12%
Jan 2026
$5.59
$5.83
+3.00%
Dec 2025
$4.58
$5.66
+18.66%
Nov 2025
$5.34
$4.77
-11.34%

CADL Share Price FAQs

What is Candel Therapeutics, Inc. share price today?

chevron-up
Candel Therapeutics, Inc. share price today is $9.68 as on October 9, 2026 at 12:28 am IST.

What is the 52 week high and 52 week low of Candel Therapeutics, Inc. stock?

chevron-up
The 52 week high of Candel Therapeutics, Inc. stock is $14.00, while the 52 week low is $4.36 as of 9 Oct '26.

What is CADL's market capitalisation today?

chevron-up
CADL market capitalisation is $512.64M as of October 9, 2026, at 12:29 am IST.

What is CADL's net income for the last quarter?

chevron-up
CADL's net income for the last quarter is -38.91B USD.

What is the 5 year returns of CADL?

chevron-up
The 5 year returns of CADL is -13.88% as on 9 Oct '26.

What is the high & low stock price of CADL today?

chevron-up
CADL stock price hit a high of $9.74 and low of $9.45 as of 9 Oct '26.

Can I buy CADL shares in India?

chevron-up
Yes. You can buy CADL in India by opening an international trading account.